Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

64 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

NCT05386108

Conditions
Brain Diseases, Brain Neoplasms, Breast Diseases, +9 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • California Research Institute Los Angeles, California, United States
  • Carle Cancer Center Urbana, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View all 86 locations
View Trial Details
Recruiting

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

NCT06780176

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • University of California, Los Angeles (Specimen Analysis only) Los Angeles, California, United States
  • University of Miami (Data Collection Only) Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center (All protocol activites) New York, United States
View Trial Details
Recruiting

A Study of Treatment-Related Toxicities and Quality of Life After Local Therapy in Chinese Breast Cancer Patients

NCT07010939

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, Beijing Municipality, China
  • Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center Shenzhen, Guangdong, China
  • Shanxi Cancer Hospital Taiyuan, Shanxi, China
View Trial Details
Recruiting

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

NCT05465031

Conditions
Angiotensin II Type 1 Receptor Blockers, Angiotensin Receptor Antagonists, Antihypertensive Agents, +24 more
Locations
  • Regional Cancer Centre in Opole Opole, Opole Voivodeship, Poland
  • Maria Sklodowska-Curie Institute - Oncology Centre (MSCI), Gliwice Branch Gliwice, Silesian Voivodeship, Poland
  • Silesian Center for Heart Diseases Zabrze, Silesian Voivodeship, Poland
  • Holy Cross Cancer Centre, Cardio-Oncology Division Kielce, Świętokrzyskie Voivodeship, Poland
View Trial Details
Recruiting

Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study

NCT06805812

Conditions
Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more
Locations
  • Centro di Riferimento Oncologico IRCCS Aviano, Italy
  • Azienda Socio Sanitaria Territoriale degli Spedali Civili Brescia, Italy
  • Humanitas Istituto Clinico Catanese Catania, Italy
  • ASST Lariana - Ospedale Sant'Anna Como, Italy
View all 24 locations
View Trial Details

Related conditions